GJA1 and diabetic foot: Cx43 is markedly upregulated in dermal tissues surrounding diabetic foot ulcers and in clinical trials treatment with the Cx43 carboxyl-terminal mimetic peptide αCT1 significantly accelerates the rate of closure of these pathologic, slow-healing wounds [8].